SCHEMBL170903

SCHEMBL170903

CC[C@H](CO)NC1CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
CNR1 P21554 1/20 0.43
ADRA1A P35348 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ABCC3 O15438 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 2/20 0.39
ALOX12 P18054 1/20 0.39
SHBG P04278 1/20 0.38
EPHX1 P07099 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRB2 P07550 1/20 0.37
EPHX2 P34913 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
DPP4 P27487 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23275968 0.96 LMNA (0.43) KDM4ELMNACNR1ADRA1ATDP1
SCHEMBL23275966 0.96 LMNA (0.43) KDM4ELMNACNR1ADRA1ATDP1
SCHEMBL7776985 0.86 KDM4E (0.52) KDM4EALDH1A1SHBGEPHX1SLC6A4
SCHEMBL29223954 0.84 KDM4E (0.43) KDM4ESMN1; SMN2ALDH1A1EPHX1ADRB2
SCHEMBL1148861 0.84 KDM4E (0.50) KDM4EALDH1A1SHBGEPHX1SLC6A4
SCHEMBL7775156 0.84 KDM4E (0.50) KDM4EALDH1A1SHBGEPHX1SLC6A4
Ammonia Solution, Strong SCHEMBL29224616 0.82 KDM4E (0.41) KDM4ESMN1; SMN2ALDH1A1EPHX1ADRB2
Ammonia Solution, Strong SCHEMBL342936 0.82 KDM4E (0.48) KDM4EALDH1A1SHBGEPHX1SLC6A4
SCHEMBL27572081 0.80 MEN1 (0.42) ALDH1A1EPHX1EPHX2MEN1KMT2A
SCHEMBL20144701 0.79 ALDH1A1 (0.43) KDM4ELMNACNR1ADRA1ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255738-B1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO NEUROCRINE BIOSCIENCES INC (US) 2012-03-07 EP disclosed